Previous studies have shown an increase in these markers in the CSF of people with Alzheimer’s disease (AD) [14, 17, 18], but in one prior study of beta-synuclein in the CSF of people with undifferentiated FTD, the levels were normal [17]. The gene discussed is SNCB; the disease is Alzheimer disease.